Connection

Thomas Uhde to Depressive Disorder

This is a "connection" page, showing publications Thomas Uhde has written about Depressive Disorder.
Connection Strength

1.260
  1. Odor sensitivity impairment: a behavioral marker of psychological distress? CNS Spectr. 2019 08; 24(4):404-412.
    View in: PubMed
    Score: 0.115
  2. Major depression in patients with panic disorder: factors associated with course and recurrence. J Affect Disord. 1990 Aug; 19(4):287-96.
    View in: PubMed
    Score: 0.066
  3. Major depression in patients with social phobia. Am J Psychiatry. 1990 May; 147(5):637-9.
    View in: PubMed
    Score: 0.064
  4. Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls. Biol Psychiatry. 1988 Jul; 24(3):322-30.
    View in: PubMed
    Score: 0.057
  5. Graphic representation of the life course of illness in patients with affective disorder. Am J Psychiatry. 1988 Jul; 145(7):844-8.
    View in: PubMed
    Score: 0.057
  6. Panic disorder and major depression. A tale of two syndromes. Psychiatr Clin North Am. 1988 Jun; 11(2):441-61.
    View in: PubMed
    Score: 0.056
  7. Ventricular-brain ratio and life course of illness in patients with affective disorder. Psychiatry Res. 1988 Mar; 23(3):277-84.
    View in: PubMed
    Score: 0.055
  8. Effect of carbamazepine on body weight in affectively ill patients. J Clin Psychiatry. 1986 Jun; 47(6):313-4.
    View in: PubMed
    Score: 0.049
  9. Effects of carbamazepine on serum electrolytes in affectively ill patients. Psychol Med. 1986 May; 16(2):331-5.
    View in: PubMed
    Score: 0.049
  10. Decreased triiodothyronines in depression: a preliminary report. Biol Psychiatry. 1985 Aug; 20(8):922-5.
    View in: PubMed
    Score: 0.046
  11. Caffeine-induced escape from dexamethasone suppression. Arch Gen Psychiatry. 1985 Jul; 42(7):737-8.
    View in: PubMed
    Score: 0.046
  12. Panic disorder and major depression: biological relationships. Psychopharmacol Bull. 1985; 21(3):551-4.
    View in: PubMed
    Score: 0.045
  13. New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine. Biol Psychiatry. 1984 Feb; 19(2):131-56.
    View in: PubMed
    Score: 0.042
  14. Treatment of mood disorders with antiepileptic medications: clinical and theoretical implications. Epilepsia. 1983; 24 Suppl 2:S97-108.
    View in: PubMed
    Score: 0.039
  15. Biological relationships between mania and melancholia. Encephale. 1982; 8(2):213-28.
    View in: PubMed
    Score: 0.036
  16. Rapid onset: a valid panic disorder criterion? Depress Anxiety. 1997; 5(3):121-6.
    View in: PubMed
    Score: 0.026
  17. Normal urinary free cortisol and postdexamethasone cortisol in social phobia: comparison to normal volunteers. J Affect Disord. 1994 Mar; 30(3):155-61.
    View in: PubMed
    Score: 0.021
  18. Diurnal rhythms and symptom severity in panic disorder. A preliminary study of 24-hour changes in panic attacks, generalised anxiety, and avoidance behaviour. Br J Psychiatry. 1992 Oct; 161:512-6.
    View in: PubMed
    Score: 0.019
  19. Acute dystonia and fluoxetine. J Clin Psychiatry. 1992 Sep; 53(9):327.
    View in: PubMed
    Score: 0.019
  20. Endocrine, cardiovascular, and behavioral effects of intravenous protirelin in patients with panic disorder. Arch Gen Psychiatry. 1991 Feb; 48(2):148-56.
    View in: PubMed
    Score: 0.017
  21. Social phobic symptoms in patients with panic disorder: practical and theoretical implications. Am J Psychiatry. 1989 Feb; 146(2):235-8.
    View in: PubMed
    Score: 0.015
  22. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications. Biol Psychiatry. 1988 Mar 15; 23(6):575-85.
    View in: PubMed
    Score: 0.014
  23. Obsessive-compulsive symptoms in panic disorder. Am J Psychiatry. 1987 Dec; 144(12):1573-6.
    View in: PubMed
    Score: 0.014
  24. Differential time course of antidepressant effects after sleep deprivation, ECT, and carbamazepine: clinical and theoretical implications. Psychiatry Res. 1987 Sep; 22(1):11-9.
    View in: PubMed
    Score: 0.013
  25. Motor activity in depressed patients treated with carbamazepine. Biol Psychiatry. 1987 Aug; 22(8):941-6.
    View in: PubMed
    Score: 0.013
  26. Blunted growth hormone response to clonidine in panic disorder patients. Biol Psychiatry. 1986 Sep; 21(11):1081-5.
    View in: PubMed
    Score: 0.012
  27. Indices of noradrenergic output in depression. Psychiatry Res. 1986 Sep; 19(1):59-73.
    View in: PubMed
    Score: 0.012
  28. Life events and course of illness in patients with panic disorder. Am J Psychiatry. 1986 Aug; 143(8):1033-5.
    View in: PubMed
    Score: 0.012
  29. Dopaminergic effects of carbamazepine. Relationship to clinical response in affective illness. Arch Gen Psychiatry. 1986 Apr; 43(4):392-6.
    View in: PubMed
    Score: 0.012
  30. Alpha 2-adrenergic receptor function in patients with unipolar and bipolar affective disorders. J Affect Disord. 1986 Mar-Apr; 10(2):163-9.
    View in: PubMed
    Score: 0.012
  31. Antidepressant effects of carbamazepine. Am J Psychiatry. 1986 Jan; 143(1):29-34.
    View in: PubMed
    Score: 0.012
  32. Differential diagnosis and treatment of panic disorder: a medical model perspective. Aust N Z J Psychiatry. 1985 Dec; 19(4):330-41.
    View in: PubMed
    Score: 0.012
  33. Biological alterations in the primary affective disorders and other tricyclic-responsive disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1985; 9(1):15-24.
    View in: PubMed
    Score: 0.011
  34. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand Suppl. 1985; 317:1-34.
    View in: PubMed
    Score: 0.011
  35. Carbamazepine in bipolar illness. Psychopharmacol Bull. 1985; 21(1):10-7.
    View in: PubMed
    Score: 0.011
  36. Carbamazepine and thyroid function in affectively ill patients. Clinical and theoretical implications. Arch Gen Psychiatry. 1984 Dec; 41(12):1150-3.
    View in: PubMed
    Score: 0.011
  37. Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects. Am J Psychiatry. 1984 Jun; 141(6):733-41.
    View in: PubMed
    Score: 0.011
  38. The effects of carbamazepine on the thyrotropin response to thyrotropin-releasing hormone. Psychiatry Res. 1984 Jun; 12(2):161-6.
    View in: PubMed
    Score: 0.011
  39. Relationship of response to sleep deprivation and carbamazepine in depressed patients. Acta Psychiatr Scand. 1984 May; 69(5):379-82.
    View in: PubMed
    Score: 0.011
  40. Plasma cortisol responses to clonidine in depressed patients and controls. Evidence for a possible alteration in noradrenergic-neuroendocrine relationships. Arch Gen Psychiatry. 1984 Jan; 41(1):63-8.
    View in: PubMed
    Score: 0.010
  41. Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response. Arch Gen Psychiatry. 1983 Jun; 40(6):673-6.
    View in: PubMed
    Score: 0.010
  42. Extreme elevations in plasma norepinephrine associated with decreased alpha-adrenergic responsiveness in major depressive disorder: two case reports. J Clin Psychopharmacol. 1983 Feb; 3(1):39-41.
    View in: PubMed
    Score: 0.010
  43. Biochemical effects of carbamazepine: relationship to its mechanisms of action in affective illness. Prog Neuropsychopharmacol Biol Psychiatry. 1983; 7(2-3):263-71.
    View in: PubMed
    Score: 0.010
  44. Clinical studies of monoamine receptors in the affective disorders and receptor changes with antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry. 1983; 7(2-3):249-61.
    View in: PubMed
    Score: 0.010
  45. Growth hormone response to clonidine unchanged by chronic clorgyline treatment. Psychiatry Res. 1982 Oct; 7(2):139-44.
    View in: PubMed
    Score: 0.010
  46. Possible subsensitization of alpha 2-adrenergic receptors by chronic monoamine oxidase inhibitor treatment in psychiatric patients. Psychiatry Res. 1982 Jun; 6(3):293-302.
    View in: PubMed
    Score: 0.009
  47. Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatry Res. 1982 Apr; 6(2):171-83.
    View in: PubMed
    Score: 0.009
  48. Effect of carbamazepine on CSF opioid activity; relationship to antidepressant response. Psychiatry Res. 1981 Aug; 5(1):59-66.
    View in: PubMed
    Score: 0.009
  49. Effects of one night's sleep deprivation on mood and behavior in panic disorder. Patients with panic disorder compared with depressed patients and normal controls. Arch Gen Psychiatry. 1986 Sep; 43(9):895-9.
    View in: PubMed
    Score: 0.003
  50. Reduced TSH and prolactin responses to TRH in patients with panic disorder. Am J Psychiatry. 1986 Apr; 143(4):503-7.
    View in: PubMed
    Score: 0.003
  51. Longitudinal course of panic disorder: clinical and biological considerations. Prog Neuropsychopharmacol Biol Psychiatry. 1985; 9(1):39-51.
    View in: PubMed
    Score: 0.003
  52. Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence. Arch Gen Psychiatry. 1984 Nov; 41(11):1067-71.
    View in: PubMed
    Score: 0.003
  53. Profile of clinical efficacy and side effect of carbamazepine in psychiatric illness: relationship to blood and CSF levels of carbamazepine and its -10,11-epoxide metabolite. Acta Psychiatr Scand Suppl. 1984; 313:104-20.
    View in: PubMed
    Score: 0.003
  54. Abnormalities in the primary affective disorders compared to other tricyclic-responsive disorders. Psychopharmacol Bull. 1983; 19(3):435-6.
    View in: PubMed
    Score: 0.002
  55. Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness. Biol Psychiatry. 1982 Sep; 17(9):1037-45.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.